ByTrending Posts
Can Bayer’s Partnership with Altis Labs’ AI Boost…
Altis’ IPRO-Δ AI model outperforms RECIST in predicting survival, signaling a major shift in oncology trial endpoint Altis-Bayer…
Is IBM and Inclusive Brains’ AI-Quantum Fusion the…
Key Highlights Advancing Accessibility Through Multimodal AI and Brain-Machine InterfacesThe collaboration aims to improve the classification accuracy of…
AI at the FDA: Will ‘Elsa’ Redefine How…
Key highlights Regulatory AI Disruption: Why the FDA’s ‘Elsa’ Tool Is a Gamechanger for Biopharma The U.S. Food…
AI in Pharmacovigilance: Why Are Top Global Biopharma…
Key Highlights Industry Confidence Grows as NavaX Gains MomentumArisGlobal, a leader in life sciences technology, has announced the…
Can the FDA’s Elsa AI Transform Medical Device…
Key Takeaways Transforming the FDA’s Mission With Secure Generative AIIn a landmark step toward modernizing regulatory science, the…
Will Sanofi’s $9.5B Acquisition of Blueprint Redefine the…
Key Takeaways for Biopharma Executives Strategic Expansion: Sanofi Bets Big on Rare Immunology and US Biotech InnovationIn a…
Can Bristol Myers Squibb and BioNTech’s $1.5B Bet…
Key Takeaways for Industry Leaders Strategic Shift: BMS Moves Deeper into Bispecific Immuno-OncologyIn a bold move signaling growing…
How GSK-Backed Onc.AI Is Using Deep Learning Radiomics…
Key Highlights: Reinventing RECIST: How Onc.AI’s Serial CTRS is Transforming Imaging BiomarkersOnc.AI is redefining how oncology imaging data…
How Massive Bio’s AI is Unlocking Global Oncology…
Key Highlights: Revolutionizing Cancer Care With Multi-Agent AI at ASCO25Massive Bio is presenting its cutting-edge AI technology at…
Trending Posts
Latest Stories
Can AstraZeneca’s $390 Million AI Investment in 2025 — Fueled by Strategic Partnerships — Accelerate Discovery, R&D, and Commercial Success in 2026?
Global – December 31, 2025 — AstraZeneca plc significantly expanded its commitment to artificial intelligence…
Can Merck’s $300 Million AI Investment in 2025 — Fueled by Strategic Partnerships — Accelerate Innovation, R&D and Commercial Success in 2026?
Global – December 31, 2025 — Merck & Co., Inc. significantly expanded its commitment to…
Can Gilead’s $260 Million AI Investment in 2025 — Backed by Strategic AI Initiatives — Accelerate Discovery, R&D, and Commercial Impact in 2026?
Global – December 31, 2025 — Gilead Sciences, Inc. expanded its commitment to artificial intelligence…
Can Sanofi’s $380 Million AI Investment in 2025 — Bolstered by Strategic Partnerships — Drive Breakthroughs in Discovery, R&D, and Commercial Success in 2026?
Global – December 31, 2025 — Sanofi S.A. made significant investments in artificial intelligence (AI)…
Gallery
